Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India.
Malani A, Shah D, Kang G, Lobo GN, Shastri J, Mohanan M, Jain R, Agrawal S, Juneja S, Imad S, Kolthur-Seetharam U. Malani A, et al. Among authors: juneja s. Lancet Glob Health. 2021 Feb;9(2):e110-e111. doi: 10.1016/S2214-109X(20)30467-8. Epub 2020 Nov 13. Lancet Glob Health. 2021. PMID: 33197394 Free PMC article. No abstract available.
City-Scale Agent-Based Simulators for the Study of Non-pharmaceutical Interventions in the Context of the COVID-19 Epidemic: IISc-TIFR COVID-19 City-Scale Simulation Team.
Agrawal S, Bhandari S, Bhattacharjee A, Deo A, Dixit NM, Harsha P, Juneja S, Kesarwani P, Swamy AK, Patil P, Rathod N, Saptharishi R, Shriram S, Srivastava P, Sundaresan R, Vaidhiyan NK, Yasodharan S. Agrawal S, et al. Among authors: juneja s. J Indian Inst Sci. 2020;100(4):809-847. doi: 10.1007/s41745-020-00211-3. Epub 2020 Nov 12. J Indian Inst Sci. 2020. PMID: 33199946 Free PMC article. Review.
What strategies to boost production of affordable fixed-dose anti-retroviral drug combinations for children in the developing world?
Dionisio D, Gass R, McDermott P, Racalbuto V, Madeo M, Braghieri G, Crowley S, Pinheiro Edos S, Graaff P, Vasan A, Eksaengsri A, Moller H, Khanna AK, Kraisintu K, Juneja S, Nicolaou S, Sengupta A, Esperti F, Messeri D. Dionisio D, et al. Among authors: juneja s. Curr HIV Res. 2007 Mar;5(2):155-87. doi: 10.2174/157016207780077075. Curr HIV Res. 2007. PMID: 17346132
Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis.
Mulder C, Rupert S, Setiawan E, Mambetova E, Edo P, Sugiharto J, Useni S, Malhotra S, Cook-Scalise S, Pambudi I, Kadyrov A, Lawanson A, van den Hof S, Gebhard A, Juneja S, Sohn H. Mulder C, et al. Among authors: juneja s. BMJ Glob Health. 2022 Jan;7(1):e007182. doi: 10.1136/bmjgh-2021-007182. BMJ Glob Health. 2022. PMID: 34992077 Free PMC article.
Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines.
Gomez GB, Siapka M, Conradie F, Ndjeka N, Garfin AMC, Lomtadze N, Avaliani Z, Kiria N, Malhotra S, Cook-Scalise S, Juneja S, Everitt D, Spigelman M, Vassall A. Gomez GB, et al. Among authors: juneja s. BMJ Open. 2021 Dec 3;11(12):e051521. doi: 10.1136/bmjopen-2021-051521. BMJ Open. 2021. PMID: 34862287 Free PMC article.
Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients.
van de Berg SEJ, Pelzer PT, van der Land AJ, Abdrakhmanova E, Ozi AM, Arias M, Cook-Scalise S, Dravniece G, Gebhard A, Juneja S, Handayani R, Kappel D, Kimerling M, Koppelaar I, Malhotra S, Myrzaliev B, Nsa B, Sugiharto J, Engel N, Mulder C, van den Hof S. van de Berg SEJ, et al. Among authors: juneja s. BMC Public Health. 2021 Jul 16;21(1):1404. doi: 10.1186/s12889-021-11427-y. BMC Public Health. 2021. PMID: 34271884 Free PMC article.
306 results